NeoGenomics, Inc. NEO
16.96 USD -0.64 (-3.64%)
At closeNov 10, 2026, 4:00 PM EST
16.96 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
16.83 Day range 17.59
7.07 52-week range 20.15
- YTD
- +44.22%
- 1 year
- +63.08%
News
businesswire.com NeoGenomics to Participate in Upcoming Investor Conferences FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in the Stephens Annual Investment Conference and the Piper Sandler 38th Annual Healthcare Conference.
benzinga.com TD Cowen Maintains Buy on NeoGenomics, Raises Price Target to $23 TD Cowen analyst Dan Brennan maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $19 to $23.
benzinga.com NeoGenomics Q3 2026 Earnings Call Transcript NeoGenomics (NASDAQ:NEO) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
benzinga.com NeoGenomics Raises FY2026 Sales Guidance from $802.000M-$806.000M to $807.000M-$809.000M vs $805.827M Est NeoGenomics (NASDAQ:NEO) raises FY2026 sales outlook from $802.000 million-$806.000 million to $807.000 million-$809.000 million vs $805.827 million estimate.
benzinga.com NeoGenomics Q3 Adj. EPS $0.07 Beats $0.05 Estimate, Sales $209.254M Beat $207.328M Estimate NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 percent. This is a 133.33 percent increase over earnings of $0.03 per…
benzinga.com What's Going On With NeoGenomics Stock Tuesday? NeoGenomics stock falls after leadership shuffle and Q3 preliminary results. Analysts weigh in on growth and valuation.
benzinga.com General Motors To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday Wall Street analysts raised targets for PTC, Cloudflare, PENN, Microsoft and others, while downgrading PTC and upgrading PENN and Abbott.
benzinga.com StoneX Maintains Buy on NeoGenomics, Raises Price Target to $20 StoneX analyst Bruce D. Jackson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $16 to $20.
benzinga.com This Boyd Gaming Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday Analysts upgraded Boyd Gaming, NeoGenomics, PENN Entertainment, XP and Rezolute, raising targets for several names.- benzinga.com Needham Maintains Buy on NeoGenomics, Raises Price Target to $22 Needham analyst Mike Matson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $19 to $22.
benzinga.com NeoGenomics Appoints President, COO Warren Stone As CEO, Effective Jan, 4 Next Year, Succeeding Tony Zook; Zook Appointed Executive Chair, Succeeding Lynn Tetrault NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that as part of a planned…- benzinga.com NeoGenomics’ RaDaR ST Molecular Residual Disease Assay Receives Expanded Coverage From CMS’ MolDX To Include Immunotherapy Monitoring For Patients With Late-Stage Solid Tumors New coverage extends RaDaR ST to patients with advanced cancer on immunotherapy, expanding MRD testing across the cancer care continuumNeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology…
benzinga.com Greenland Mines Outlines $2B Valuation for Sarfartoq Project Greenland Mines released an Initial Assessment for its Sarfartoq project, projecting a pre-tax net present value up to $2.05 billion.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's regular session. The market value of their outstanding shares is at $1.4 million. SciSparc (NASDAQ:SPRC)…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday's pre-market session. The company's market cap stands at $1.4 million. OneMedNet (NASDAQ:ONMD) shares…- benzinga.com Needham Maintains Buy on NeoGenomics, Raises Price Target to $19 Needham analyst Mike Matson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $15 to $19.
- benzinga.com NeoGenomics Raises FY2026 Sales Guidance from $797.000M-$803.000M to $802.000M-$806.000M vs $800.433M Est NeoGenomics (NASDAQ:NEO) raises FY2026 sales outlook from $797.000 million-$803.000 million to $802.000 million-$806.000 million vs $800.433 million estimate.
- benzinga.com NeoGenomics Q2 Adj. EPS $0.05 Beats $0.03 Estimate, Sales $202.000M Beat $196.997M Estimate NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 66.67 percent increase over earnings of $0.03…
- benzinga.com Benchmark Maintains Buy on NeoGenomics, Raises Price Target to $16 Benchmark analyst Bruce D. Jackson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $11 to $16.
benzinga.com NeoGenomics Reveals Settlement Of Voluntary Disclosure To OIG-HHS; Co To Pay $9,813,260 Plus Interest At A Rate Of 4.250% Per Annum From January 16, 2026 To Resolve The Matter NeoGenomics, Inc. (the "Company") (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it has finalized a civil settlement with the…- benzinga.com NeoGenomics Launches PTEN IHC CDx, Immunohistochemistry Companion Diagnostic Test Approved By FDA For Patients With Prostate Adenocarcinoma Available within NEO PanTracer™ Pro for prostate cancer and as a standalone test, PTEN IHC CDx identifies patients who may be eligible for TRUQAP®NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of…
benzinga.com NeoGenomics Prices Offering Of $275M Of 0.75% Convertible Senior Notes Due 2032 In addition, NeoGenomics granted the initial purchasers of the notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the notes are first…- benzinga.com NeoGenomics Commences A Private Offering Of $275M Aggregate Principal Amount Of Convertible Senior Notes Due 2032 solutions that enable precision medicine, announced today that it has commenced a private offering of $275 million aggregate principal amount of convertible senior notes due 2032 (the "notes") to…
benzinga.com NeoGenomics To Showcase Eight Scientific Abstracts, Highlighting Advances In MRD, Precision Oncology, And Real-World Evidence Across Solid Tumors And Hematologic Malignancies, At 2026 ASCO Annual Meeting NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced it will showcase eight scientific abstracts at the 2026 American…
benzinga.com Earnings Scheduled For May 12, 2026 - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com Earnings Scheduled For April 28, 2026
- benzinga.com Earnings Scheduled For March 19, 2026
- benzinga.com Earnings Scheduled For February 17, 2026
benzinga.com Ryvyl, NeoGenomics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - benzinga.com Earnings Scheduled For November 14, 2025
benzinga.com Earnings Scheduled For October 28, 2025 
benzinga.com Alibaba To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Affirm Posts Better-Than-Expected Earnings, Joins Ambarella, IREN, Petco Health and Wellness And Other Big Stocks Moving Higher On Friday 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com Earnings Scheduled For August 12, 2025
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com Earnings Scheduled For July 29, 2025
- benzinga.com Earnings Scheduled For May 9, 2025
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings - benzinga.com Earnings Scheduled For April 29, 2025
- benzinga.com Earnings Scheduled For March 18, 2025
- benzinga.com Earnings Scheduled For February 18, 2025
- benzinga.com Earnings Scheduled For November 14, 2024
- benzinga.com Shake Shack And Lumen Tech Are Among Top 7 Mid Cap Stocks With Max Gains Last Week (July 28-August 3): Are The Others In Your Portfolio? Seven mid-cap stocks that performed well last week: LUMN, SHAK, PSN, CWAN, RGEN, FTDR, and NEO. Check if they're in your portfolio!
- benzinga.com Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday